Biological Sensors May Provide Physicians with Insights on Whether Treatments Are Effective
Patients suffering from potentially fatal diseases, such as cancer, may often undergo weeklong gaps that are discomforting when their courses of treatment begins. Doctors use this period to learn whether a patient’s treatment is working, and while it’s the standard way of doing things, the approach prevents health-care professionals from tracking the disease’s progression in real time. Enter Glympse Bio, a start-up that originated from Sangeeta Bhatia’s laboratory. Sangeeta Bhatia is the Marble Center for Cancer Nanomedicine director as well as an MIT Professor of Electrical Engineering and Computer Science. The start-up has developed small synthetic biosensors that can be…
